Lu JJ - Search Results

1

Reirradiation of locally recurrent nasopharyngeal cancer: history, advances, and promises for the future.

Kong L, Lu JJ. Kong L, et al. Among authors: lu jj. Chin Clin Oncol. 2016 Apr;5(2):26. doi: 10.21037/cco.2016.03.19. Chin Clin Oncol. 2016. PMID: 27121886 Free article. Review.

2

Twice-daily prophylactic cranial irradiation for patients with limited disease small-cell lung cancer with complete response to chemotherapy and consolidative radiotherapy: report of a single institutional phase II trial.

Wolfson AH, Bains Y, Lu J, Etuk B, Sridhar K, Raub W, Markoe A. Wolfson AH, et al. Am J Clin Oncol. 2001 Jun;24(3):290-5. doi: 10.1097/00000421-200106000-00017. Am J Clin Oncol. 2001. PMID: 11404503 Clinical Trial.

3

Adjuvant high-dose rate brachytherapy after chemoradiation for treatment of early T-stage nasopharyngeal carcinoma.

Lu JJ, Shakespeare T, Goh BC, Tiong CE, Back M, Mukherjee R, Wynne CJ, Tan KS. Lu JJ, et al. Am J Clin Oncol. 2004 Apr;27(2):132-5. doi: 10.1097/01.coc.0000046592.90778.fc. Am J Clin Oncol. 2004. PMID: 15057151

4

The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.

Kong L, Lu JJ, Hu C, Guo X, Wu Y, Zhang Y. Kong L, et al. Among authors: lu jj. Cancer. 2006 Sep 15;107(6):1287-93. doi: 10.1002/cncr.22119. Cancer. 2006. PMID: 16909425 Free article.

5

Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.

Lu JJ, Kong L, Shakespeare TP, Loh KS, Zhang Q, Tan KS, Lee KM. Lu JJ, et al. Oral Oncol. 2008 Jul;44(7):703-9. doi: 10.1016/j.oraloncology.2007.09.005. Epub 2007 Dec 3. Oral Oncol. 2008. PMID: 18061528 Clinical Trial.

6

The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.

Pan J, Kong L, Lin S, Chen G, Chen Q, Lu JJ. Pan J, et al. Among authors: lu jj. Laryngoscope. 2008 Nov;118(11):1970-5. doi: 10.1097/MLG.0b013e3181805134. Laryngoscope. 2008. PMID: 18758376

7

Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.

Lin S, Pan J, Han L, Zhang X, Liao X, Lu JJ. Lin S, et al. Among authors: lu jj. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1071-8. doi: 10.1016/j.ijrobp.2008.12.015. Epub 2009 Apr 11. Int J Radiat Oncol Biol Phys. 2009. PMID: 19362784

8

Anatomic and dosimetric changes during the treatment course of intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma.

Wang X, Lu J, Xiong X, Zhu G, Ying H, He S, Hu W, Hu C. Wang X, et al. Med Dosim. 2010 Summer;35(2):151-7. doi: 10.1016/j.meddos.2009.06.007. Epub 2009 Jul 23. Med Dosim. 2010. PMID: 19931037

9

Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?

Gao Y, Zhu G, Lu J, Ying H, Kong L, Wu Y, Hu C. Gao Y, et al. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1397-402. doi: 10.1016/j.ijrobp.2009.06.062. Epub 2010 Jan 13. Int J Radiat Oncol Biol Phys. 2010. PMID: 20044215

10

Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.

Tham IW, Lin S, Pan J, Han L, Lu JJ, Wee J. Tham IW, et al. Among authors: lu jj. Am J Clin Oncol. 2010 Jun;33(3):294-9. doi: 10.1097/COC.0b013e3181d2edab. Am J Clin Oncol. 2010. PMID: 20395788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,023 results

Search Page

Filters